SearchDictionaryMobileLogin

B A C Dijkmans Selected Research

Rheumatoid Arthritis

08/2008Increased prevalence of antithyroid antibodies in rheumatoid arthritis (RA) patients with a low prevalence of hormonal alterations.
08/2008The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
07/2008[The formation of infliximab and anti-infliximab immune complexes as an explanation for non-responding to infliximab treatment of rheumatoid arthritis: observational study in 4 patients]
07/2008Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus.
06/2008Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.
05/2008[The diagnostic accuracy of anti-citrulline antibody assessment in the diagnosis of patients suspected of rheumatoid arthritis by a general practitioner]
05/2008Progression of joint damage in early rheumatoid arthritis: Association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
11/20072-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.
08/2007Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage.
08/2007Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
07/2007Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
07/2007Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.
03/2007Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis.
02/2007Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.
02/2007Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis.
11/2006Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.
05/2006Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.
04/2006Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis.
01/2006Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
07/2005Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
05/2005Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
04/2005Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
03/2005[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]
02/2005Bone mineral density in patients with rheumatoid arthritis treated with infliximab.
09/2004Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis.
10/2003Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab.
09/2003Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.
04/2003Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
01/2003Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview.
01/2003Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al.

Articles by Research Topic

Disease

30Rheumatoid Arthritis
08/2008 - 01/2003
7Ankylosing Spondylitis
01/2007 - 11/2002
3Arthritis (Polyarthritis)
02/2008 - 10/2004
2Osteoporosis
05/2007 - 11/2005
1Arthralgia (Joint Pain)
09/2008
1Necrosis
08/2008
1Diabetes Mellitus
07/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2008
1Osteoarthritis
11/2007
1Rheumatic Diseases (Rheumatism)
05/2007
1Inflammation
02/2007
1Skin Diseases
07/2006
1Cardiovascular Diseases (Cardiovascular Disease)
05/2006
1Acute-Phase Reaction
04/2006
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2005
1Psoriatic Arthritis
06/2005
1Reactive Arthritis (Reiter Disease)
09/2004
1Paraplegia (Spastic Paraplegia)
01/2003

Drug/Important Bio-Agent (IBA)

12infliximab (Remicade)FDA Link
08/2008 - 10/2003
5Methotrexate (Mexate)FDA LinkGeneric
07/2008 - 04/2003
4AntibodiesIBA
08/2008 - 08/2005
3Alendronate (Alendronate Sodium)FDA LinkGeneric
05/2007 - 11/2005
3Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2006 - 04/2003
2Antigen-Antibody Complex (Immune Complex)IBA
07/2008 - 02/2007
2AutoantibodiesIBA
04/2006 - 03/2005
2leflunomide (Arava)FDA LinkGeneric
12/2005 - 09/2004
1cyclic citrullinated peptideIBA
09/2008
1Anti-Idiotypic AntibodiesIBA
09/2008
1cartilage matrix proteinIBA
06/2008
1CitrullineIBA
05/2008
1Rheumatoid FactorIBA
05/2008
1HLA-DRB1 antigen (HLA DRB1)IBA
05/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2007
1Interferon Type IIBA
08/2007
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2007
11-hydroxycholecalciferol (alfacalcidol)IBA
05/2007
1FructosamineIBA
03/2007
1adalimumab (Humira)FDA Link
03/2007
1LipidsIBA
02/2007
1OsteoprotegerinIBA
11/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2006
1Prednisone (Sone)FDA LinkGeneric
01/2006
1pamidronate (APD)FDA LinkGeneric
11/2005
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
09/2005
1Fibrinogen (Factor I)IBA
08/2005
1C-Reactive ProteinIBA
05/2005
1Transforming Growth Factor beta (TGF-beta)IBA
04/2005
1Toll-Like Receptor 4IBA
02/2005
1TNFR-Fc fusion protein (etanercept)FDA Link
12/2004
1AntimetabolitesIBA
10/2004
1Azithromycin (Zithromax)FDA LinkGeneric
09/2004
1HDL CholesterolIBA
09/2003
1GlucocorticoidsIBA
09/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2003
1P-GlycoproteinsIBA
01/2003
1Interleukin-1 (Interleukin 1)IBA
12/2002
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2002
1Antirheumatic Agents (DMARD)IBA
11/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2008